SCHEMBL8970432

SCHEMBL8970432

COc1cccc2c1CC(CNCCCN(C)S(=O)(=O)c1ccc(F)cc1)CC2

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.48
CHRM1 P11229 3/20 0.48
CHRM3 P20309 3/20 0.48
MTNR1A P48039 6/20 0.42
MTNR1B P49286 6/20 0.42
CYP1A2 P05177 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX15 P16050 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8970496 0.97 CHRM2 (0.48) CHRM2CHRM1CHRM3MTNR1AMTNR1B
SCHEMBL8970649 0.87 BACE1 (0.47) CHRM2CHRM1CHRM3MTNR1AMTNR1B
SCHEMBL8970412 0.86 CHRM2 (0.48) CHRM2CHRM1CHRM3CA1CA2
SCHEMBL8969041 0.84 CHRM2 (0.51) CHRM2CHRM1CHRM3MTNR1AMTNR1B
SCHEMBL8970736 0.81 NPY5R (0.47) CHRM2CHRM1CHRM3MTNR1AMTNR1B
SCHEMBL8969014 0.80 CHRM2 (0.43) CHRM2CHRM1CHRM3KMT2A
SCHEMBL8970480 0.77 MTNR1A (0.53) CHRM2CHRM1CHRM3MTNR1AMTNR1B
SCHEMBL8970393 0.73 TAS2R14 (0.45) CHRM2CHRM1CHRM3KMT2A
SCHEMBL8969631 0.73 MTNR1A (0.51) CHRM2CHRM1CHRM3MTNR1AMTNR1B
SCHEMBL8970546 0.72 DRD2 (0.43) CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
EP-0352613-B1 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1994-04-20 EP disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed